Table 2.

Observed depression, anxiety, and stress symptom severity and putative targets

	Baseline		5 week follow-up		10 week follow-up		3 month postpartum follow-up
	BA	TAU	BA	TAU	BA	TAU	BA	TAU
PHQ-9 mean (SD), n	14.83 (3.47) n = 86	14.60 (3.20) n =77	11.56 (4.77) N=67	12.00 (4.56) N=64	8.76 (5.39) N=70	10.46 (4.71) N=68	6.52 (6.67) N=64	8.10 (6.11) N=66
GAD-7, mean (SD), n	13.23 (4.30) n =86	13.50 (4.01) n =77	10.43 (4.80) N=67	11.50 (5.01) N=64	8.07 (5.50) N=70	10.87 (4.84) N=68	5.94 (5.77) N=64	8.80 (5.78) N=66
PSS mean (SD), n	26.40 (5.38) n =86	25.73 (4.76) n =77	23.49 (6.16) N=67	24.68 (6.70) N=64	19.08 (7.11) N=70)	22.79 (5.90) N=68	15.96 (8.51) N=64	20.50 (7.10) N=66
BADS mean (SD), n	21.70 (7.45) n =86	22.21 (6.15) n =77	25.85 (7.88) N=67	22.51 (7.55) N=63	29.28 (10.49) N=70	24.40 (8.16) N=68	33.42 (9.41) N=64	28.49 (8.88) N=65
EROS mean (SD), n	22.48 (4.75) n =86	22.55 (3.76) n =77	23.97 (4.35) N=67	22.54 (4.21) N=63	26.79 (6.45) N=70	23.59 (4.71) N=68	29.35 (6.33) N=64	26.25 (5.62) N=65

Note. BA = Behavioral Activation; TAU = Treatment as Usual; PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized Anxiety Disorder 7-item Questionnaire; PSS = Perceived Stress Scale; BADS = Behavioral Activation for Depression Scale -- Short Form; EROS = Environmental Reward Observation Scale.